Opioid Peptides and Blood Pressure Control
11th Scientific Meeting of the International Society of Hypertension Satellite Symposium · Bonn · September 6-7, 1986
1st Edition
Published on 22. June 1988
Book
Paperback/Softback
VIII, 300 pages
978-3-540-18935-0 (ISBN)
Description
A. !, FADEN, K. KRAFr, and K. O. STUMPE Following the discovery of the pentapeptide enkephalins in 1975, a number of endogenous opioid peptides and opiate receptors have been identified. Endogenous opioids and opiate-receptor mechanisms have been implicated in a variety of regulat- ory and dysregulatory functions including analgesia, cardiovascular regulation, shock, hypertension, traumatic spinal cord and brain injury, stroke, immune func- tion, feeding behavior, diuresis, gastrointestinal motility, and respiratory control, among others. Over the past 10 years, many studies have demonstrated a relationship between endogenous opioids and the cardiovascular system under both homeostatic and pathophysiological conditions. Opioids and opiate receptors have been found in various cardioregulatory sites within the brain and spinal cord, as well as in peripheral tissues such as sympathetic ganglia, adrenal gland, and heart. Both endogenous opioids and exogenous opiates have been shown to produce potent cardiovascular effects following central nervous system or systemic administration.
Opiate-receptor antagonists have been demonstrated to reverse hypotension from sepsis, hypo- volemia, and anaphylaxis; such studies have been used to infer activity of endogenous opioid systems in shock. Changes in tissue concentrations of endogenous opioids and! or opiate receptors have been found after shock and hypertension, further implying a role for opioid systems in the etiology of these conditions. In addition, modification of opiate receptor regulation, receptor binding, or opioid metabolism has also been used to establish a potential role for endogenous opioid systems in cardiovascular control and dyscontrol.
Opiate-receptor antagonists have been demonstrated to reverse hypotension from sepsis, hypo- volemia, and anaphylaxis; such studies have been used to infer activity of endogenous opioid systems in shock. Changes in tissue concentrations of endogenous opioids and! or opiate receptors have been found after shock and hypertension, further implying a role for opioid systems in the etiology of these conditions. In addition, modification of opiate receptor regulation, receptor binding, or opioid metabolism has also been used to establish a potential role for endogenous opioid systems in cardiovascular control and dyscontrol.
More details
Language
English
Place of publication
Berlin
Germany
Publishing group
Springer Berlin
Target group
Professional and scholarly
Research
Illustrations
VIII, 300 p.
Dimensions
Height: 244 mm
Width: 170 mm
Thickness: 17 mm
Weight
542 gr
ISBN-13
978-3-540-18935-0 (9783540189350)
DOI
10.1007/978-3-642-73429-8
Schweitzer Classification
Other editions
Additional editions
K.O. Stumpe | Karin Kraft | Alan I. Faden
Opioid Peptides and Blood Pressure Control
11th Scientific Meeting of the International Society of Hypertension Satellite Symposium · Bonn · September 6-7, 1986
E-Book
12/2012
Springer
€96.29
Available for download
Content
Endogenous Opioids and Cardiovascular Regulation: Introduction.- Anatomy.- Distribution of Opioid Peptides Functionally Related to the Cardiovascular System.- Studies on Enkephalinergic Mechanisms in Cardiovascular Centers of the Medulla Oblongata of the Rat and their Interactions with Centrally Administered Neuropeptide Y.- Multiplicity of Opioidergic Pathways Related to Cardiovascular Innervation: Differential Contribution of All Three Opioid Precursors.- Physiology.- Opioids, Opiate Receptors, and Central Cardiovascular Regulation.- Adrenergic Opioid Interaction in the Brain Stem: Role in Cardiovascular Regulation.- Influence of the Opioid System on Sympathetic Activity and the Renin-Aldosterone System in Healthy Males.- Role of Leu-morphin, an Opioid Peptide, in the Central Regulation of Fluid Balance and Blood Pressure in Rats.- Endogenous Opioids in the Dorsal Vagal Complex and Resting Cardiovascular Function in the Anesthetized Rat.- Influence of Opiate Peptides on Blood Pressure Regulation and on Hypothalamic Blood Flow.- Opioid Peptides in Human Adrenal Medulla: Their Role in the Modulation of Catecholamine Secretion.- Cardiovascular Effects of Neuropeptide Y in the Caudal Ventrolateral Medulla.- Plasma Met-enkephalin and Cardiovascular Responses to Stress.- Pharmacology.- Opioid Receptors in the Sympathetic Supply to Blood Vessels and the Heart.- Interactions of Opioid Peptides and Adrenergic Agents in the Regulation of Blood Pressure.- Effect of Opiate Receptor Blockade on the Cardiovascular and Plasma Noradrenaline Response to Intravenous Tyramine in Man.- Effects of Mu- and Delta-Opiate Receptor Agonists on Systemic and Regional Hemodynamics in Conscious Rats.- Retardment of Development of Hypertension in the Spontaneously Hypertensive Rat by Long-Term Kappa-Opioid Receptor Antagonism.- Naltrexone Inhibits Alpha-Methydopa-Induced Hypotension in a Dose-Dependent Manner.- Effects of 17-alpha-estradiol, a Possible Endogenous Opiate Antagonist, on Cardiovascular Responses in Conscious Unrestrained Rats.- Opioid Receptor Types at Noradrenergic Neurons and their Roles in Blood Pressure Regulation.- Effect of Opioids on Plasma Levels of Immunoreactive Atrial Natriuretic Factor.- Production by Systemic Enkephalin of Hemodynamic Effects by Afferent Modulation of Autonomic Nervous System Tone.- Pathophysiology and Clinical Aspects.- Endogenous Opioids in the Pathophysiology of Shock: Sites of Action, Autonomic Involvement, and Receptor Interactions.- Endogenous Opioids and Blood Pressure in Man.- Effects of Hemorrhagic Shock on Plasma Met-enkephalin, Vasopressin, Catecholamines, and Cardiovascular Functions in Intact and Adrenalectomized Dogs.- Effect of Hypertension on the Response of Plasma Beta-Endorphin to the Cold Pressor Test.- Normalization by Clonidine of Reduced Plasma Beta-endorphin and Leu-enkephalin Concentrations and Elevated Blood Pressure in Young Patients with Mild Essential Hypertension.- Role of Opioids in the Pathophysiology of Hypertension.- Effect of Low Dosage of Naloxone on Clonidine-Induced Changes in Blood Pressure, Catecholamines, Renin, and Aldosterone in Essential Hypertension.- Effect of Lisinopril on Circulating Neuropeptides in Essential Hypertensive Patients.- Endogenous Opioids and Reversal of Renovascular Hypertension.- Comparison of Pain Threshold as Assessed by Tooth Pulp Stimulation in Normotensives with Different Hypertensive Hereditary Backgrounds and in Borderline and Established Hypertensives.